Gut microbiota market forecast with demand and growth insights

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Gut Microbiota Market Grow Between 2026 And 2030?

The gut microbiota market size has experienced rapid growth in recent years. It is projected to expand from $0.65 billion in 2025 to $0.77 billion in 2026, achieving a compound annual growth rate (CAGR) of 18.0%. The growth observed in the past can be attributed to an enhanced understanding of gut health and immunity, an increase in dietary supplement consumption, the expansion of functional food markets, a rise in academic research on microbiota, and growing consumer awareness of digestive health.

The gut microbiota market is anticipated to experience substantial expansion in the coming years, projected to reach $1.47 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.7%.

This growth during the forecast period is propelled by factors such as the intensified development of therapeutics aimed at the microbiome, increased investments in gut health research, the broadening of personalized nutrition platforms, the wider adoption of microbiome diagnostics, and a heightened emphasis on preventive healthcare solutions. Key trends expected over this period involve a greater uptake of probiotic and prebiotic items, an escalating interest in personalized nutrition strategies, advancements in research for microbiome-based treatments, the wider consumption of functional and fermented foods, and improved utilization of gut health diagnostic instruments.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/gut-microbiota-global-market-report

What Key Factors Are Shaping The Gut Microbiota Market Landscape?

The escalating need for personalized medicine is projected to drive the expansion of the gut microbiota market going forward. Personalized medicine entails tailoring medical interventions to individual patients based on their genetic, environmental, and lifestyle characteristics to optimize results and enhance care. The demand for personalized medicine is on the rise as breakthroughs in genomics and biotechnology facilitate more accurate identification of genetic profiles, enabling customized treatments that improve efficacy and mitigate adverse effects. Personalized medicine benefits gut microbiota by adapting treatments according to an individual’s unique microbiome composition, thereby enhancing gut health and improving outcomes for various digestive and metabolic disorders. For instance, in February 2024, data from the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, indicated that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, marking a significant rise compared to the 12 approved in 2022. Consequently, the increasing demand for personalized medicine is fueling the growth of the gut microbiota market.

How Is The Gut Microbiota Market Broken Down By Segment Categories?

The gut microbiota market covered in this report is segmented –

1) By Product: Prebiotics, Probiotics, Drugs, Supplements, Other Products

2) By Application: Digestive Health, Immune Health, Weight Management, Mental Health, Cardiovascular Health

3) By Distribution Channel: Pharmacies And Drugstores, Online Retail, Health Food Stores, Supermarkets And Hypermarkets, Specialty Stores

4) By End-Users: Adults, Children, Elderly

Subsegments:

1) By Prebiotics: Fructooligosaccharides (Fos), Galactooligosaccharides (Gos), Inulin, Resistant Starch, Beta-Glucans, Arabinogalactans, Pectins

2) By Probiotics: Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Bacillus, Escherichia

3) By Drugs: Antibiotics, Bacteriophage Therapy, Gut Microbiota Modulators, Immunomodulators, Antidiarrheal Agents, Laxatives

4) By Supplements: Synbiotics, Postbiotics, Enzyme Supplements, Vitamin D Supplements, Omega-3 Fatty Acids, Herbal Extracts

5) By Other Products: Functional Foods, Fermented Foods, Beverages, Gut Health Diagnostic Kits, Dietary Fiber Products

What Market Trends Are Affecting The Gut Microbiota Market?

Leading companies in the gut microbiota market are concentrating on developing innovative solutions, such as orally administered fecal microbiota, to address various gastrointestinal diseases and disorders. Orally administered fecal microbiota refers to a treatment where a capsule or pill containing beneficial bacteria from a healthy donor’s stool is consumed to restore balance to the gut microbiome. For instance, in April 2023, Seres Therapeutics Inc., a US-based microbiome therapeutics platform company, received FDA approval for Vowst, which is the first oral fecal microbiota product designed to prevent recurrent Clostridioides difficile (C. difficile) infection (CDI) in individuals aged 18 and older. Vowst is intended for use after antibacterial treatment for recurrent CDI. This approval signifies a significant advancement in CDI treatment, offering a more accessible and patient-friendly alternative to traditional fecal microbiota transplants, which are typically administered via colonoscopy or enema. Its oral formulation may enhance treatment adherence and expand the adoption of microbiome-based therapies in healthcare.

Which Players Are Present In The Gut Microbiota Market Space?

Major companies operating in the gut microbiota market are Danone S.A., DuPont de Nemours Inc., International Flavors & Fragrances Inc., Seres Therapeutics, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., Lifeway Foods Inc., BioGaia AB, Probi AB, Seed Health, Enterome, Vedanta Biosciences Inc., Evolve BioSystems Inc., Winclove Probiotics B.V., Kallyope Inc., Sun Genomics Inc., Synlogic Inc., OpenBiome, Codex Labs Corp.

Get The Full Gut Microbiota Market Report:

https://www.thebusinessresearchcompany.com/report/gut-microbiota-global-market-report

Which Region Holds The Highest Market Share In The Gut Microbiota Market?

North America was the largest region in the gut microbiota market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gut microbiota market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Gut Microbiota Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/gut-microbiota-global-market-report

Browse Through More Reports Similar to the Global Gut Microbiota Market 2026, By The Business Research Company

Probiotics Food And Cosmetics Market Report 2026

https://www.thebusinessresearchcompany.com/report/probiotics-food-and-cosmetics-global-market-report

Microbiomes Market Report 2026

https://www.thebusinessresearchcompany.com/report/microbiomes-global-market-report

Probiotics Market Report 2026

https://www.thebusinessresearchcompany.com/report/probiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795